Historic First Day of Personal Adult-Use Sales and Preservation of Medicinal Cannabis Market

New Jersey Law Journal (reprinted with permission)

5.13.2022

This New Jersey Law Journal article co-authored by Wilentz attorney Natalie Moszczynski, and Epstein, Becker & Green attorney Lisa Gora, examines "how the NJ Cannabis Regulatory Commission is ensuring continued access and availability for medicinal cannabis patients, now that the product is also available to recreational users."

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.